BioNet Achieves EU-GMP Certification for its Pertussis Vaccine Manufacturing Lyon, France – October 29, 2025, BioNet today announced it has received European Union Good Manufacturing Practice (EU-GMP) certification, an internationally recognized benchmark of pharmaceutical quality and compliance, to produce its acellular…